Jiangxi Synergy Pharmaceutical Co., Ltd.
SZSE:300636.SZ
10.41 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 106.584 | 105.983 | 100.667 | 81.12 | 70.051 | 48.309 | 24.531 | 65.458 | 57.996 | 62.879 | 39.208 | 16.884 | 8.028 |
| Depreciation & Amortization
| 114.766 | 69.394 | 66.884 | 51.583 | 52.327 | 42.765 | 23.86 | 20.766 | 20.299 | 15.271 | 12.614 | 2.689 | 2 |
| Deferred Income Tax
| 0 | 0 | 5.469 | 7.213 | 8.008 | 3.359 | 1.795 | 0.155 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 17.338 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 38.543 | -39.563 | -4.276 | -11.516 | -52.71 | -124.581 | 25.633 | -53.374 | -18.917 | -3.631 | 3.546 | 0 | 0 |
| Accounts Receivables
| -12.492 | 22.408 | -11.519 | -61.275 | 55.857 | -44.364 | -5.358 | -28.921 | 7.946 | -1.206 | -10.614 | 0 | 0 |
| Inventory
| -55.661 | -45.201 | -131.239 | -42.796 | -97.325 | -84.021 | -19.84 | -9.669 | -35.055 | -22.412 | -3.788 | 0 | 0 |
| Accounts Payables
| 0 | -23.011 | 133.013 | 85.342 | -19.25 | 0.444 | 49.036 | -14.939 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 106.696 | 6.241 | 5.469 | 7.213 | 8.008 | 3.359 | 45.472 | -43.705 | 16.139 | 18.781 | 7.334 | 0 | 0 |
| Other Non Cash Items
| 25.296 | 27.934 | 9.914 | 10.152 | 10.398 | 5.234 | 0.909 | 1.205 | 1.067 | 4.903 | 9.134 | -16.884 | -8.028 |
| Operating Cash Flow
| 285.19 | 163.749 | 195.997 | 131.339 | 80.066 | -28.272 | 74.933 | 34.054 | 60.445 | 79.422 | 64.502 | 14.417 | -2.717 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -136.493 | -214.653 | -311.493 | -424.671 | -229.994 | -184.496 | -242.372 | -115.108 | -28.878 | -78.532 | -31.239 | -34.202 | -31.676 |
| Acquisitions Net
| 0 | 0 | 1.118 | 0.438 | 230.595 | 0.563 | 246.021 | 0 | 0.873 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -447.006 | -653.964 | -80 | -20 | -25 | -0.563 | -332.51 | -519.58 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 77.36 | 160 | 50 | 0.02 | 25.068 | 37.47 | 519.526 | 305.508 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.487 | 2.411 | -1.611 | 0 | -229.994 | 0.563 | -242.372 | 6.16 | 0.873 | 0.95 | 0.05 | -34.202 | -31.676 |
| Investing Cash Flow
| -505.653 | -706.206 | -341.986 | -444.213 | -229.325 | -146.464 | -51.707 | -323.02 | -28.006 | -77.582 | -31.189 | -34.202 | -31.676 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -65.772 | 155.041 | 107.165 | 216.781 | 73.805 | 188.004 | 0 | -32 | 10.1 | -48.6 | -12.5 | 35.8 | 27.94 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 9.694 | 7.569 | 0 | -6.566 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.425 | 0 | 0 | -9.694 | -7.569 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -29.117 | -26.913 | -32.111 | -10.936 | -10.928 | -3.337 | -8.944 | -0.426 | -1.43 | -4.01 | -10.289 | -8.693 | -3.949 |
| Other Financing Activities
| -16.084 | 827.131 | -6.484 | -18.167 | 346.728 | -0.827 | -4.538 | 306.716 | 0.164 | 47.687 | -18.639 | 1.245 | 12.111 |
| Financing Cash Flow
| -110.974 | 955.259 | 68.571 | 187.679 | 397.748 | 176.271 | -13.483 | 267.725 | 8.834 | -4.923 | -41.428 | 28.352 | 36.101 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 4.047 | 1.823 | 1.126 | -0.738 | -4.12 | 0.244 | 0.576 | -1.227 | 0.881 | 0.071 | -0.003 | -0.055 | -0.001 |
| Net Change In Cash
| -327.39 | 414.624 | -76.293 | -125.933 | 244.369 | 1.779 | 10.319 | -22.469 | 42.155 | -3.012 | -8.117 | 8.512 | 1.707 |
| Cash At End Of Period
| 165.412 | 492.802 | 78.178 | 154.471 | 280.404 | 36.034 | 34.255 | 23.937 | 46.405 | 4.25 | 7.262 | 15.379 | 6.867 |